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The locus of enterocyte effacement (LEE) is a 35.6 kb pathogenicity island inserted in the genome of some bacteria such as
enteropathogenic Escherichia coli, enterohemorrhagic E.coli, Citrobacter rodentium, and Escherichia albertii. LEE comprises the
genes responsible for causing attaching and effacing lesions, a characteristic lesion that involves intimate adherence of bacteria to
enterocytes, a signaling cascade leading to brush border and microvilli destruction, and loss of ions, causing severe diarrhea. It is
composed of 41 open reading frames and five major operons encoding a type three system apparatus, secreted proteins, an adhesin,
called intimin, and its receptor called translocated intimin receptor (Tir). LEE is subjected to various levels of regulation, including
transcriptional and posttranscriptional regulators located both inside and outside of the pathogenicity island. Several molecules
were described being related to feedback inhibition, transcriptional activation, and transcriptional repression.These molecules are
involved in a complex network of regulation, including mechanisms such as quorum sensing and temporal control of LEE genes
transcription and translation. In this mini review we have detailed the complex network that regulates transcription and expression
of genes involved in this kind of lesion.
1. Introduction
Attaching and effacing (A/E) is a histological lesion that
occurs in intestinal epithelial cells as consequence of infection
by a group of pathogens that includes enteropathogenic
Escherichia coli (EPEC), enterohemorrhagic Escherichia coli
(EHEC), rabbit diarrheagenic Escherichia coli (RDEC), the
murine pathogen Citrobacter rodentium, and Escherichia
albertii [1]. The A/E lesion was first described by Moon
et al. 1983 [2] and is characterized by intimate attachment
of bacteria to the enterocyte membrane, destruction of the
brush border microvilli, and striking cytoskeletal changes
that include accumulation of polymerized actin beneath the
site of attachment, forming pedestal-like structures [3–6].
The intimate attachment of A/E pathogens to enterocyte
surface is mediated through interactions of the bacterial
outermembrane protein intimin and the translocated intimin
receptor (Tir) [7]. Tir and other effector proteins are delivered
to the host cell via a type III secretion system (T3SS).
The genes responsible for A/E lesion phenotype are
encoded on a 35.6 Kb pathogenicity island known as locus of
enterocyte effacement (LEE) [2, 6, 8, 9], which comprises the
structural components of type III secretion system (TTSS),
regulators, chaperones, and effectors secreted by the TTSS.
LEE was first described in EPEC E2348/69 by Mcdaniel et al.
1995 [10] and consists of 41 ORFs functionally organized into
five operons called LEE1, LEE2, LEE3, LEE4, and LEE5 [11].
LEE1,LEE2, andLEE3harbors the esc and sep genes, encoding
the major components of type III secretion system [12].
LEE1 harbors the LEE encoded regulator (ler) gene, which
encodes Ler, a DNA binding protein which acts as a main
transcriptional regulator of the LEE region, modulating the
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expression of other LEE operons [13]. The LEE5 operon con-
tains the EPEC attaching and effacing (eae) and translocated
intimin receptor (tir) genes, which encodes the adhesion
intimin and its receptor Tir, respectively.The effector proteins
translocated via type III secretion system to the host cell are
encoded by espAespB, espD, sepL, espF, and escF genes, located
at LEE4 operon [9, 14, 15].
Enteropathogenic Escherichia coli (EPEC) are among
the most important pathogens causing persistent diarrhea
in children and adults worldwide [6, 16–18]. Outbreaks of
EPEC were frequent in developed countries in the 1940s and
1950s [19] but have largely disappeared from industrialized
countries. However, EPEC continues to be an important
cause of child mortality in developing countries. In Brazil
and other developing countries, EPEC is associated with at
least 20% of the cases of diarrhea [18, 20–22]. EPEC have
been divided into two subgroups: typical EPEC (tEPEC) and
atypical EPEC (aEPEC), based on the presence or absence
of the EPEC adherence factor plasmid (pEAF), respectively
[6, 23]. Atypical EPEC has been shown to be more prevalent
than typical EPEC in developed and developing countries
and is considered an emergent cause of endemic diarrhea in
children and diarrhea outbreaks in adults [3–5].
Enterohemorrhagic Escherichia coli (EHEC) are a leading
cause of bloody diarrhea and hemolytic uremic syndrome
(HUS) throughout the world [24]. EHEC strains of the
O157:H7 serotype are the most important EHEC pathogens
in North America, the United Kingdom, and Japan [6].
This strain has been associated with numerous outbreaks
worldwide and constitutes a serious public health threat.
EHEC produces a potent Shiga toxin (Stx) that is responsible
for themajor symptoms of hemorrhagic colitis andHUS [25].
Although their sites of infection are different, EPEC
infects the small bowel and EHEC colonizes the large bowel,
these two E. coli pathotypes share a similarmode of infection,
since both are A/E pathogens [6]. EPEC and EHEC must
control virulence gene expression during infection aiming for
maximal energy efficiency. Regulation of LEE gene expres-
sion is a highly complex and coordinated process, dependent
on environmental conditions, quorum sensing, and several
regulators and regulatory pathways, in a direct or indirect
way.
This review is focused on summarizing the current
knowledge of regulation of LEE gene expression in EPEC and
EHEC and themolecules involved in this regulation are listed
in Table 1.
2. LEE-Encoded Regulators
The central regulator which controls the expression of LEE
genes is Ler, a 15 kDa protein encoded by the first gene of
the LEE1 operon, which is a HNS-like regulatory protein
[11, 13, 26–29]. Ler is essential for the formation ofA/E lesions,
since nonpolar ler mutants of EPEC and EHEC were unable
to form A/E lesions on HEp-2 cells [13]. In addition, these
lermutants failed to express type III secreted proteins, which
means that all genes known to be important in A/E lesion
formation are regulated by Ler [13]. Since Ler expression is
central to regulation of virulence genes, it is true that the
regulation of Ler expression is important to pathogenesis. In
fact, Ler expression is under control of numerous regulatory
factors, encoded in or out of the LEE region.
Global regulator of LEE activator (GrlA) and global
regulator of LEE repressor (GlrR), two other LEE-encoded
regulators, were described by Deng et al. 2004 [30] in a C.
rodentium background. These regulators are encoded by the
grlRA operon located between the rorf3 gene and the LEE2
operon in LEE. GrlA has been shown to play a key role
in the regulation of ler and thus in the expression of LEE
genes. The observation that transcription of LEE1, LEE2, and
LEE5 was diminished in grlA mutants and the transcription
of LEE1 was mildly elevated in grlR mutants has suggested
the activator and repressor roles of LEE gene transcription
to GrlA and GrlR, respectively. GrlA has been shown to bind
on LEE1 promoter and positively regulate Ler expression. Ler
also controls the expression of the grlRA operon, forming
a positive regulatory loop that ensures the appropriate level
of Ler to activate LEE gene expression [31]. Using a yeast
two-hybrid system, it was reported that GrlR specific binds
to GrlA [32]. This interaction represses LEE gene expression
by preventing GrlA interaction with LEE1 promoter [33] or
rather prevents repression by GrlR, which inhibits LEE gene
transcription specifically and independently of its interaction
with GrlA [34].
3. Non-LEE-Encoded Regulators
As the LEE is an essential virulence determinant of pathogen-
esis of EPEC and EHEC, the expression of its genes is under
control of a myriad of transcriptional regulators.
In typical EPEC, the LEE genes are regulated by a region
located on a 90 kb EPEC adherence factor plasmid (EAF
plasmid) called plasmid encoded regulator (Per). The per
locus includes perA, perB, and perC transcribed as a single
polycistronicmessage [35]. Mellies et al. (1999) demonstrated
that Per indirectly activates LEE2 and LEE3 in this pathogen.
PerC directly activates LEE1 promoter and then Ler acts
on LEE2, LEE3, LEE4, and LEE5 promoters. Bustamante et
al. (2001) have shown that perC gene is indirectly required
for LEE2 and LEE3 transcription. PerC have been reported
to induce ler transcription independently of GrlA [36].
In EHEC, a family of functional prophage-encoded PerC
homologous proteins, called PchA, PchB, and PchC, plays an
important role in ler expression [37]. Moreover, a PerC-like
protein family identified from EHEC genome analyses, PerC1
(also termed PchABC), can also activate both promoters in a
manner similar to that of EPEC PerC. PerC1 proteins are able
tomediate activation of the EPEC and EHEC LEE1 promoters
in a PerC-like manner, while PerC2 (and PerC3) seems to
be inactive. This finding correlates with the fact that PerC1
is more closely related to PerC than is PerC2, andmuchmore
so than PerC3 [38].
H-NS is a 15.6 kDa nucleoid-associated protein that binds
nonspecifically to DNA and modulates, mostly negatively,
the expression of genes involved in many different cellular
processes, including virulence [34]. H-NS plays an important
role in the repression of LEE genes [13, 28, 30]. It binds
to EPEC LEE1, LEE2, LEE3, and LEE5 regulatory regions,
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Table 1: Regulators involved in LEE genes transcription.
Regulator Bacteria Regulatory mechanism Phenotype/response References
LEE-encoded
GrlA C. rodentium;EPEC, EHEC Binding LEE1 promoter
Activates LEE expression
through Ler Deng et al., 2004 [30]
GrlR C. rodentium;EPEC, EHEC
Binding to GrlA preventing
it to bind LEE-1 promoter
Represses Ler/LEE
expression Deng et al., 2004 [30]
Ler A/E pathogens Binding to LEE promoters Activates expression of allLEE operons Elliott et al., 2000 [13]
Non-LEE encoded
BipA EPEC, EHEC Activates ler transcription Activates LEE expressionthrough Ler Grant et al., 2003 [46]
Cpx EPEC, EHEC Downregulates LEE4 andLEE-5 transcription Represses LEE expression Macritchie et al., 2008 [51]
Fis EPEC Activates ler and LEE4transcription Activates LEE expression Goldberg et al., 2001 [45]
GadE EHEC Represses LEE expression Vanaja et al., 2009 [50]
Hha EHEC Binding ler promoter Represses Ler transcription Sharma and Zuerner, 2004 [48]
H-NS EPEC, EHEC
Binding to LEE1, LEE2,
LEE3 and LEE5 regulatory
region
Represses Ler expression Bustamante et al., 2001 [28]
IHF EPEC Binding upstream to lerpromoter
Activates ler, orf3, orf5, and
orf2 expression Friedberg et al., 1999 [26]




Iyoda and Watanabe, 2004, [44]
Porter et al., 2005 [38]
PerC Typical EPEC Activating LEE1 promoter Activates LEE expression Mellies et al., 1999 [11]
RgdR EHEC Activating LEE1transcription Activates LEE expression Flockhart et al., 2012 [47]
RpoN EHEC Activating grlA, repressinggadE Activates LEE expression Riordan et al., 2010 [49]
SspA EHEC Repressing H-NSexpression Activates LEE expression Goldberg et al., 2001 [45]
FusK/R EHEC Represses LEE1 Represses LEE expression Pacheco et al., 2012 [68]
EutR EHEC Activates LEE1 Activates LEE expression Kendall et al., 2012 [69]
LeuO EHEC Activates LEE1 Activates LEE expression Takao et al., 2014 [67]








Tomoyasu et al., 2005 [56];
Iyoda and Watanabe, 2005 [37]
CsrA EPEC




transcript and protein levels
Positively regulates LEE
expression Bhatt et al., 2009 [55]
DegP EPEC Protease and chaperoneactivity Represses LEE expression Macritchie et al., 2012 [52]
DsrA EHEC Affecting the levels offunctional transcripts of ler Activates LEE expression Laaberki et al., 2006 [58]
Hfq EHEC Acting in ler and grlRAmRNA
Activates or represses LEE
expression, depending on
the strain background
Shakhnovich et al., 2009 [63];
Hansen and Kaper, 2009 [64];
Kendall et al., 2011 [65]
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Table 1: Continued.
Regulator Bacteria Regulatory mechanism Phenotype/response References
RNaseE EHEC
Splicing at the C-terminal
end of sepL in the precursor
sepL espADB transcript
Generates the sepL and
espADB transcripts Lodato and Kaper, 2009 [53]
RpoS EHEC Binding to ler promoter
Activates or represses LEE
expression, depending on
the strain background
Sperandio et al., 1999 [57];
Laaberki et al., 2006 [58];
Tomoyasu et al., 2005 [56];
Iyoda and Watanabe, 2005 [37]
Quorum sensing
KdpE EHEC Binding to ler promoter Activates LEE expression Njoroge et al., 2013 [70]
QseA EPEC, EHEC Binding to ler promoter Activates LEE transcription Sperandio et al., 2002 [80];Sircili et al., 2004 [71]
QseC EHEC Phosphorylation of KdpERR Activates LEE expression Sperandio et al., 2002 [80]
QseD EHEC Binding to ler promoter Represses LEE transcription Habdas et al., 2010 [83]
QseE EHEC Inhibiting RcsB RRtranscription Represses LEE expression
Reading et al., 2007 [81];
Njoroge et al., 2013 [70]
RcsB EHEC O157:H7;EHEC Sakai Activates LEE transcription Njoroge et al., 2013 [70]
GlmY/GLMz EHEC Regulates transcription ofLEE4 and LEE5
Gruber and Sperandio, 2014
[66]
directly controlling LEE transcription [29, 39]. It has been
shown that different transcriptional regulators can counteract
the repression mediated by H-NS on the expression of
virulence genes [40–42]. Ler can neutralize the silencing
exerted by H-NS on LEE promoters [28, 30, 36] but not on
its own promoter that is also repressed by H-NS [30]. Ler
binds with higher affinity than H-NS to the same region of
LEE5 and LEE2, disrupting H-NS-containing nucleoprotein
complexes [27, 28, 43].The E. coli stringent starvation protein
A (SspA) is involved in downregulation of the cellular H-NS
level during stationary phase [36, 44]. It also has a role in
positive regulation of virulence genes in EHEC, since it was
demonstrated that in the absence of SSpA, EHEC produces
high levels of H-NS which represses the expression of LEE
genes, rendering cells incapable of forming A/E lesions [45].
Friedberg et al. (1999) demonstrated that integration host
factor (IHF) is essential for expression of LEE-encoded type
III secretion genes and directly activates LEE1 transcriptional
unit. IHF acts by disrupting the Ler repression by HNS
binding specifically upstream from the ler promoter to
activate expression of ler, orf3, orf5, and orf2 directly [26].The
overcoming of H-NS silencing of the ler promoter requires
the combined antirepressor activity of IHFwith PerC or GrlA
[34].
Another nucleoid-associated protein that has an impact
upon virulence gene expression in EPEC is the factor for
inversion stimulation (Fis). Fis was reported to positively
regulate ler and LEE4 expression. Goldberg et al. (2001)
[45] have shown that major EPEC secreted proteins (EspA,
EspB, and EspD) were found to be significantly reduced
and that ler expression was abolished in the Δfis mutant,
resulting in inability to induce A/E lesion. However, tir and
intimin expressions were found to be unaffected in these
mutants, which suggest that the promoter of this operon is
not regulated by Fis.
In EPEC, the ribosome-binding GTPase BipA has been
shown to modulate virulence expression by increasing LEE
transcription, since several key proteins encoded by LEE had
lower levels in the absence of BipA. Transcription of ler was
reduced in the absence of BipA, suggesting that this GTPase
acts most likely indirectly through activating expression of
Ler [46].
Recently, Flockhart et al. (2012) [47] have reported a
new LEE regulator, termed RgdR, that is encoded in CP-
933 prophage of O157:H7 and activates LEE1 transcription in
the presence or absence of Ler. Sharma and Zuerner (2004)
[48] have reported that EHEC O157:H7 mutants of hha gene
showed 10-fold increase of ler transcription, suggesting that
Hha acts as a repressor of ler transcription by binding to its
promoter.
Alternative sigma factor 54 (RpoN) is one of seven RNA
polymerase sigma subunits in E. coli required for promoter-
initiated transcription. RpoN was shown to positively reg-
ulate the expression of genes in all five LEE operons [49],
perhaps through indirect activation of grlA. RpoN may also
regulate LEE through GadE, since gadE expression was
upregulated in ΔrpoN mutant [48]. GadE is a transcriptional
activator of the glutamate decarboxylase (GAD) system of E.
coli and has been reported to repress LEE expression in a ler
dependent fashion [50].
The Cpx two-component system regulates an envelope
stress response adapted by Escherichia coli to monitor and
maintain cell envelope integrity. This pathway also has a
direct effect on transcription of virulence genes and virulence
regulators in different pathogens. Activation of the Cpx
pathway negatively affects EPECTTSS by downregulating the
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expression of components of the translocation apparatus as
well as the receptor Tir [51]. Cpx pathway is capable of inhibit-
ing LEE expression in a nonpathogenic E. coli background,
which suggests that Cpx-mediated inhibition of LEE gene
expression and TTSS is independent of Ler. Cpx response
might also inhibit T3SS in EPEC at posttranscriptional levels
and DegP is a contributing factor in this inhibition [52].
Whereas our knowledge about the mechanisms of tran-
scriptional regulation of the LEE is vast, our understanding
of posttranscriptional and posttranslational regulation is lim-
ited. In term of posttranscriptional and posttranslational reg-
ulation, RNase E generates the sepL and espADB transcripts
by splicing at the C-terminal end of sepL in the precursor
sepLespADB transcript of EHEC [53]. CsrA, anRNA-binding
protein [54], is a posttranscriptional regulator molecule in
A/E pathogens that activates and represses the expression of
LEE-encoded genes in a concentration-dependent manner
[55]. CsrA exerts its effect by binding to the leader segment
of the sepLespADB mRNA and enhancing the steady-state
transcript and protein levels.
ClpX and ClpP were suggested to be positive regulatory
genes that control expression of LEE in EHEC O157. It was
shown that O157:H7 Sakai clpPX mutant strongly impaired
the secretion of virulence proteins by TTSS and repressed
transcription from all the LEE promoters. This positive
regulation partially depends on the intracellular levels of
RpoS, a substrate for the ClpXP protease, since the ΔrpoS
mutation in O157:H7 Sakai enhanced the transcription from
all the LEE promoters and the secretion of virulence proteins,
and it could partially suppress the defects of the ΔclpPX
mutation. However, the regulation of LEE by ClpXP also
occurs in a sigma-(S-) independent pathway that involves the
negative regulation of GrlR levels in EHEC [37, 56].
The stress sigma factor RpoS has also been involved
in regulatory cascades controlling LEE expression [37, 57].
The effects of RpoS on expression of the LEE virulence
genes appear to vary depending on strain backgrounds and
experimental conditions. Laaberki et al. (2006) [58] have
reported that the LEE3 operon and tir are positively regulated
by RpoS in EHEC strain 86-24. However, in EHEC O157:H7
Sakai strain, LEE expression is enhanced in rpoS mutants
[37, 56, 58] due to increases in ler mRNAs levels [58],
indicating that RpoS could repress ler expression. RpoS acts
by binding to ler promoter to activate the transcription
through a pathway different than that used by H-NS. In
turn, RpoS translation depends on the high levels of DsrA,
a noncoding RNA (ncRNA) which modulates the expression
of RpoS and H-NS.
Noncoding RNAs (ncRNAs) have recently emerged as
important regulators involved in controlling the expression of
regulatory and effector genes [59]. DsrA acts by an antisense
base-pairing mechanism on H-NS mRNA, decreasing its
stability, and on RpoS mRNA, stimulating its translation
[60, 61]. DsrA enhances ler expression by affecting the levels
of functional transcripts and theDsrA-mediated activation of
LEE requires Ler. DsrA effects on the expression of intimin
and EspA would mainly be due to its effect on ler expression
and the DsrA activation of ler expression requires RpoS [58].
DsrA also affects the H-NS levels; however RpoS- and HNS-
dependent pathways separately regulate ler expression.
Hfq is a conserved RNA-binding protein that regulates
diverse cellular processes through posttranscriptional control
of gene expression, often by functioning as a chaperone for
regulatory sRNAs in many bacterial species [62]. Hfq has
been described as a negative regulator of the expression of
all of the 41 LEE genes acting directly upon ler mRNA,
as translation of this transcript is increased in the absence
of Hfq in EHEC EDL933 [63]. Hansen and Kaper (2009)
have shown that Hfq negatively affects LEE expression in
exponential phase by regulating the expression of the LEE-
encoded regulators GrlA and GrlR at the posttranscriptional
level by destabilizing grlRA mRNA. Hfq negatively affects
LEE expression in stationary phase independent of GrlA and
GrlR in EHEC EDL933 [64]. However, Kendall et al. (2011)
have reported that Hfq plays a regulatory role in EHEC 86-
24 that is different from what has been reported for EHEC
strain EDL933, acting as a positive regulator of the TTSS
expression andA/E lesion formation in this strain [65]. Taken
together, these studies point to the possibility that this kind of
regulation might be different even in closely related strains.
Recently, Gruber and Sperandio noticed that LEE and
espFu genes are posttranscriptionally regulated by the
GlmY/GlmZ sRNAs. GlmY and GlmZ promote cleavage of
the intergenic region between espJ and espFu to allow the
translation of EspFu [66].
4. Environmental Signals Such as
Carbon Sources
There are recent studies correlating some carbon sources to
LEE regulation. Takao et al. 2014 noticed that LeuO can
recognize butyrate and activate a signaling cascade. LeuO
expression induces prolonged activation of the promoter of
LEE1 operon, including the ler gene, as well as virulence
mechanisms such as microcolony formation. Activation of
the LEE1 promoter by LeuO depends on another regulator,
called Pch. The response of the leuO promoter to butyrate
requires two virulence regulators, Pch and Ler, in addition
to Lrp. Pch, Ler, and Lrp bind the upstream region of the
leuO promoter. Thus, leuO is involved in butyrate-enhanced
expression of LEE genes through a positive feedback mecha-
nism, but its expression and action on the LEE1 promoter are
dependent on the virulence regulators Pch and Ler [67].
Another sugar that is highly abundant in the intes-
tine is fucose. Recently, Pacheco et al. described a mecha-
nism of fucose recognition and virulence regulation. They
described one novel two-component signal transduction
system, named FusKR, where FusK is the histidine sensor
kinase and FusR the response regulator. FusK senses fucose
and controls expression of virulence and metabolic genes.
This fucose-sensing system is required for robust EHEC colo-
nization of the mammalian intestine [68]. Ethanolamine can
act as a signal to modulate virulence. The EutR transcription
factor, known to be the receptor of EA, is only partially
responsible for this regulation, suggesting that yet another
EA receptor exists. Ethanolamine (EA) is present in the large
intestine due to the turnover of intestinal cells. Kendall et
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al. 2012 showed that during growth at early log phase, ler
expression in WT EHEC was increased over 10-fold when
EA was added to the medium. At mid- and late log phases,
the addition of EA did not significantly affect the level of
ler transcription [69]. Njoroge et al., 2013 studied the role of
Cra and KdpE and concluded that although these regulators
clearly have individual targets, they also share either conver-
gent or divergent regulation of subsets of genes. Cra positively
regulate the genes encoding gluconeogenic enzymes, and
negatively regulate genes encoding glycolytic enzymes. Cra
and KdpE converge in the regulation of the LEE T3SS and
several non-LEE-encoded effectors, which agrees with the
fact that the expression of these genes should be coupled, even
though they are found in different chromosomal regions.
Both transcription factors activate LEE1 expression under
gluconeogenic conditions. Another factor involved in the
trigger of AE lesion is the phosphorylation of Tir and the
accessory protein EspFu/Tccp [70].
5. Quorum Sensing and Signaling Systems
Several signaling systems have been well studied between
host-cell pathogens interactions; among them there are
at least four involved in chemical signaling described in
the literature: (1) AI-1 System, (2) AI-2 System, (3) AI-
3/epinephrine system, and (4) indole. At least two systems
were described in mechanisms involved in LEE gene regu-
lation in EPEC and EHEC strains.
The first study reporting quorum sensing regulation of
LEE in EHEC and EPEC was performed by Sperandio et
al. (1999). In this pioneering study, they noticed that the
transcription of LEE1 and LEE2was increased in the presence
of preconditioning media, suggesting that EPEC and EHEC
secrete AI-2 [57]. At that time point it was proposed that AI-2
acts by activating these operons and thus positively regulating
the expression of TTSS genes. Another study performed by
Sircili et al. 2004 using one E2348/69 EPEC strain noticed
that qseA and luxS were involved in LEE genes transcription
altering TTSS expression and reducing A/E lesion formation
[71]. Later studies noticed that AI-2 was not involved in this
mechanism of regulation, and the molecule involved was
actually AI-3.
6. AI-1 System and Indole
Escherichia coli does not harbor one luxI homologue and
does not produce the autoinducer, although it harbors one
luxR homologue which is called sdiA. SdiA is responsible for
sensing the environmental AI-1 signals produced by other
microorganisms [72]. Studies with SdiAmutants have shown
that this regulator may be involved in biofilm formation in
E. coli. SdiA has been proposed to interact with indole [73],
in addition to acyl homoserine lactones (AHLs) from other
bacteria. However, conclusive data demonstrating that SdiA
senses that indole is lacking. In E. coli, SdiA, named after its
ability to suppress cell division inhibitors, is a 240-amino-
acid protein that belongs to the LuxR family of transcriptional
regulators. Sheng et al. 2013 noticed that deletion of sdiA
removes the ability to sense AHLs and regulate LEE and
gad gene expression, and as a result the sdiA mutant did
not grow well in rumen and was defective, compared to
the WT, for colonization of the RAJ mucosa of these cattle.
They report that these animals, still harbor AHLs in their
rumen, and these AHLs can still repress ler and increase gad
gene expression in an SdiA-dependent way [74]. One recent
work of Bommarius et al., showed that indole derivatives
also represses production of LEE virulence factors and inhibit
pedestal formation on mammalian cells [75].
7. AI-3/Epinephrine/Norepinephrine System
AI-3/epinephrine/norepinephrine system was first described
in enterohemorrhagic E. coliO157:H7 (EHEC) strains [76]. It
was initially thought that the gene responsible for production
of the molecule was luxS, since luxS mutant has diminished
AI-3 production. Another study performed by Sperandio’s
group showed that luxSmutants have metabolic deficiencies,
and luxS is not responsible for AI-3 production [77]. The
AI-3 signal is an aromatic compound, and the host hormones
epinephrine and norepinephrine can restore AI-3-dependent
phenotypes in EHEC. Based on that, it has been proposed
that this system is involved in host cell-bacteria commu-
nication, and interkingdom signaling. The AI-3 receptor,
QseC sensor kinase [78] has been extensively described in
EHEC and other species. Subsequent studies showed that AI-
3/epinephrine/norepinephrine system is not restricted to E.
coli strains [79].
EHEC and EPEC luxS mutant both present diminished
AI-3 production and do not express the LEE-encoded T3SS
system at normal levels, nonetheless still form AE lesions
on epithelial cells that were indistinguishable from those
seen with wild type. luxS mutants were still responding to
eukaryotic cell signals to activate expression of the LEE genes.
These signals were identified as the hormones epinephrine
and norepinephrine. Epinephrine and norepinephrine can
substitute for AI-3 to activate transcription of the LEE genes,
type III secretion, and AE lesions on epithelial cells.
In EHEC, the mammalian hormones epinephrine and
norepinephrine, which are released by the host during
stress, are sensed by the QseC receptor to regulate bacterial
virulence genes [80, 81]. The qseC mutant is attenuated
for virulence, which underscores the importance of this
interkingdom communication to the development of disease
[78]. Regarding atypical EPEC, we performed studies using
one qseC mutant and noticed a similar pattern of regulation
(unpublished results).
Concerning the EHEC AI-3/epinephrine/norepineph-
rine signaling system cascade, there are other transcriptional
regulators involved; however the timing and interactions still
need more studies to be elucidated. We can cite some of
these molecules, such as QS E. coli regulator (QseA) [80].
QseA is transcriptionally activated through QS and, in turn,
binds to and directly activates transcription of the LEE-
encoded regulator Ler. Interestingly, qseA mutant in EPEC
has a similar reduction in TTSS, but has defect in motil-
ity [71], suggesting a different kind of regulation between
these two pathotypes, at least regarding these two strains
tested. Another two-component system, named QseBC is
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Figure 1: Schematic representation of LEE genes transcription regulation. The pointed arrows indicate activation, and repression is
represented by blunt arrows.
responsible for the transcriptional activation of the flagella
regulon in response to QS. Early studies indicated that an
isogenic mutant in the qseC sensor kinase was unable to
respond toAI-3 or epinephrine given exogenously [78].There
are other genes recently described in this signaling cascade,
and it is important to notice the identification of qseE and
qseF (encoding a second two-component system), which are
involved in regulating AE [81]. Additionally, QseE has also
been shown to sense epinephrine, sulphate, and phosphate,
but not AI-3 [82]. The AI-3-dependent QS signaling cascade
is present in all Enterobacteriaceae (E. coli, Salmonella spp.,
Shigella spp., and Yersinia spp.). The most striking feature is
that the genes encoding the transcriptional factors of this cas-
cade are always in the exact same context in the chromosome
of all these strains and share high levels of identity among
these different species, suggesting that this signaling cascade
is functionally conserved in Enterobacteriaceae.
8. Concluding Remarks
Elucidation of the kinetics of AE lesion formation dem-
onstrated that this complex phenotype is tightly regulated
in response to environmental signals, and there are several
molecules and mechanisms involved in this regulation. It is
important to notice that there are a lot of molecules and
environmental signals involved in this pathogenicity island
regulation, and this very complex cascade of regulators helps
to activate or repress virulence, sensing the conditions of
the environment and pointing to the colonization process.
We must understand these mechanisms and these regulators
because these molecules can be targets to block the virulence
factors transcription and translation, consecutively prevent-
ing the colonization. We demonstrate the complex signaling
cascade on a scheme (Figure 1).
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